ISIN | LU1819585453 |
---|---|
Valorennummer | |
Bloomberg Global ID | |
Fondsname | Bellevue Sustainable Healthcare I2 |
Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fondsanbieter | Bellevue Asset Management AG |
Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare sector taking account of sustainability criteria. The fund can also invest in companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of “healthcare sector”, the healthcare sector includes companies from the areas of pharmaceuticals, medical technology, biotechnology and related sectors. |
Besonderheiten |
Aktueller Preis * | 178.26 USD | 19.09.2024 |
---|---|---|
Vorheriger Preis * | 177.14 USD | 18.09.2024 |
52 Wochen Hoch * | 182.04 USD | 30.08.2024 |
52 Wochen Tief * | 148.73 USD | 27.10.2023 |
NAV * | 178.26 USD | 19.09.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 126'676'998 | |
Anteilsklassevermögen *** | ||
Trading Information SIX |
YTD-Performance | +10.02% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
---|---|---|
YTD-Performance (in CHF) | +10.79% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
1 Monat | +0.54% |
19.08.2024 - 19.09.2024
19.08.2024 19.09.2024 |
3 Monate | +7.64% |
21.06.2024 - 19.09.2024
21.06.2024 19.09.2024 |
6 Monate | +9.74% |
19.03.2024 - 19.09.2024
19.03.2024 19.09.2024 |
1 Jahr | +12.52% |
19.09.2023 - 19.09.2024
19.09.2023 19.09.2024 |
2 Jahre | +18.51% |
19.09.2022 - 19.09.2024
19.09.2022 19.09.2024 |
3 Jahre | -10.53% |
20.09.2021 - 19.09.2024
20.09.2021 19.09.2024 |
5 Jahre | -10.41% |
15.06.2021 - 19.09.2024
15.06.2021 19.09.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Regeneron Pharmaceuticals Inc | 3.40% | |
---|---|---|
Eli Lilly and Co | 3.40% | |
Intuitive Surgical Inc | 3.38% | |
Vertex Pharmaceuticals Inc | 3.17% | |
Insulet Corp | 3.14% | |
UCB SA | 2.89% | |
Boston Scientific Corp | 2.85% | |
Biomarin Pharmaceutical Inc | 2.83% | |
IQVIA Holdings Inc | 2.76% | |
Cardinal Health Inc | 2.75% | |
Letzte Daten-Aktualisierung | 31.08.2024 |
TER | 1.40% |
---|---|
Datum TER | 29.01.2021 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | 1.34% |
SRRI ***
|
|
Datum SRRI *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** |
Sustainable Investment |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |